| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2007/08/30 | 05 : 45 | PR Newswire (US) | American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc. | AMEX:AVN | |
| 2006/02/01 | 22 : 00 | PR Newswire (US) | Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors | AMEX:AVN | |
| 2006/01/18 | 06 : 15 | Business Wire | AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2006/01/11 | 22 : 35 | Business Wire | AVANIR Licenses Docosanol 10% Cream in Japan | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2006/01/11 | 22 : 30 | Business Wire | AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2006/01/06 | 21 : 30 | Business Wire | AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2006/01/05 | 06 : 00 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2006/01/03 | 22 : 30 | Business Wire | Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/11/24 | 06 : 10 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/11/14 | 23 : 00 | Business Wire | AVANIR Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/11/03 | 06 : 56 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the CIBC and the Rodman & Renshaw Healthcare Conference Webcasts | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/10/19 | 03 : 14 | Business Wire | AVANIR Announces $16 Million Common Stock Offering | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/09/27 | 22 : 00 | Business Wire | AVANIR Pharmaceuticals Appoints Craig Wheeler to Board Of Directors | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/09/22 | 21 : 00 | Business Wire | Further Update on AVANIR's Neurodex(TM) New Drug Application | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/09/17 | 05 : 55 | Business Wire | AVANIR Pharmaceuticals Invites Investors to the Bank of America and the UBS Global Life Sciences Conference Webcasts | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/09/01 | 08 : 56 | Business Wire | Update on AVANIR's Neurodex(TM) New Drug Application | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/08/15 | 22 : 00 | Business Wire | AVANIR Pharmaceuticals Reports Third Quarter Fiscal 2005 Financial Results | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/07/12 | 03 : 26 | Business Wire | AVANIR Announces Corporate Update Conference Call | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/07/11 | 22 : 15 | Business Wire | AstraZeneca and AVANIR Announce Global Alliance to Discover and Develop Novel Reverse Cholesterol Transport Enhancing Compounds | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/07/06 | 22 : 00 | Business Wire | AVANIR Strengthens Its Sales and Marketing Team | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/07/05 | 22 : 00 | Business Wire | AVANIR Pharmaceuticals Added to 2005 Russell Indices | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/06/30 | 20 : 30 | Business Wire | AVANIR Submits NDA for Neurodex(TM) | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/06/23 | 22 : 00 | Business Wire | AVANIR Initiates Phase III Clinical Trial of Neurodex for the Treatment of Diabetic Neuropathic Pain | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/06/21 | 07 : 04 | Business Wire | AVANIR Pharmaceuticals Files Shelf Registration Statement | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/06/07 | 02 : 11 | Business Wire | AVANIR's Investigational Anthrax Antibody Effective in Recognized Animal Model; UTMB Scientists Present Data at ASM Meeting | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/06/04 | 03 : 31 | Business Wire | AVANIR Invites Investors to Webcast of Pacific Growth Equities Life Sciences Growth Conference Presentation | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/06/01 | 02 : 33 | Business Wire | AVANIR Amends Terms of Existing Warrant; Warrant to Expire if Not Exercised by July 26, 2005 | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/05/13 | 21 : 30 | Business Wire | Webcast Alert: AVANIR Pharmaceuticals Announces Its Second Quarter 2005 Conference Call Webcast | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2005/05/11 | 06 : 54 | Business Wire | AVANIR Pharmaceuticals Invites Investors to Its Second Fiscal Quarter 2005 Conference Call on May 16, 2005 | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |
| 2003/12/29 | 19 : 00 | PR Newswire (US) | New Research Gives Hope to Stroke Survivors with Uncontrolled Emotions | AMEX:AVN | 12% Strides Linked TO Apple, Inc. |